What are the risks of investing in RNA?
R
What are the risks of investing in RNA?
🦉
Atrium Therapeutics, Inc. (RNA)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOKathleen Gallagher
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2...
Key Executives
| Name | Title |
|---|---|
| Brendan Winslow | Chief Financial Officer |
| Husam Younis | Chief Scientific Officer |
| Kathleen Gallagher | President, CEO & Director |
| Rocio Martin Hoyos | Chief Strategy Officer |
| Stephanie Kenney | Chief Corporate Affairs Officer |
| Steven George Hughes | Chief Medical Officer |
Risk Assessment
Weather Score0/100
RegimeN/A